229 related articles for article (PubMed ID: 9788958)
41. Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptor.
Rosenkilde MM; Schwartz TW
Mol Pharmacol; 2000 Mar; 57(3):602-9. PubMed ID: 10692502
[TBL] [Abstract][Full Text] [Related]
42. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
Salcedo R; Resau JH; Halverson D; Hudson EA; Dambach M; Powell D; Wasserman K; Oppenheim JJ
FASEB J; 2000 Oct; 14(13):2055-64. PubMed ID: 11023990
[TBL] [Abstract][Full Text] [Related]
43. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists.
McColl SR; Clark-Lewis I
J Immunol; 1999 Sep; 163(5):2829-35. PubMed ID: 10453028
[TBL] [Abstract][Full Text] [Related]
45. The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors.
Yamin R; Kaynan NS; Glasner A; Vitenshtein A; Tsukerman P; Bauman Y; Ophir Y; Elias S; Bar-On Y; Gur C; Mandelboim O
PLoS Pathog; 2013 Aug; 9(8):e1003568. PubMed ID: 23966863
[TBL] [Abstract][Full Text] [Related]
46. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
Katancik JA; Sharma A; de Nardin E
Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
[TBL] [Abstract][Full Text] [Related]
47. The Viral G Protein-Coupled Receptor ORF74 Hijacks β-Arrestins for Endocytic Trafficking in Response to Human Chemokines.
de Munnik SM; Kooistra AJ; van Offenbeek J; Nijmeijer S; de Graaf C; Smit MJ; Leurs R; Vischer HF
PLoS One; 2015; 10(4):e0124486. PubMed ID: 25894435
[TBL] [Abstract][Full Text] [Related]
48. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
Sodhi A; Montaner S; Gutkind JS
FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
[TBL] [Abstract][Full Text] [Related]
49. CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo.
Zhang XW; Liu Q; Wang Y; Thorlacius H
Br J Pharmacol; 2001 Jun; 133(3):413-21. PubMed ID: 11375258
[TBL] [Abstract][Full Text] [Related]
50. Sulfotyrosines of the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promote tumorigenesis through autocrine activation.
Feng H; Sun Z; Farzan MR; Feng P
J Virol; 2010 Apr; 84(7):3351-61. PubMed ID: 20106924
[TBL] [Abstract][Full Text] [Related]
51. The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells.
Cannon ML; Cesarman E
Oncogene; 2004 Jan; 23(2):514-23. PubMed ID: 14724579
[TBL] [Abstract][Full Text] [Related]
52. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
[TBL] [Abstract][Full Text] [Related]
53. Selective induction of the monocyte-attracting chemokines MCP-1 and IP-10 in vesicular stomatitis virus-infected human monocytes.
Bussfeld D; Nain M; Hofmann P; Gemsa D; Sprenger H
J Interferon Cytokine Res; 2000 Jul; 20(7):615-21. PubMed ID: 10926203
[TBL] [Abstract][Full Text] [Related]
54. Multiple sites on IL-8 responsible for binding to alpha and beta IL-8 receptors.
Schraufstätter IU; Barritt DS; Ma M; Oades ZG; Cochrane CG
J Immunol; 1993 Dec; 151(11):6418-28. PubMed ID: 8245475
[TBL] [Abstract][Full Text] [Related]
55. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Punjabi AS; Carroll PA; Chen L; Lagunoff M
J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
[TBL] [Abstract][Full Text] [Related]
56. Molecular aspects, genomic arrangement and immune responsive mRNA expression profiles of two CXC chemokine receptor homologs (CXCR1 and CXCR2) from rock bream, Oplegnathus fasciatus.
Umasuthan N; Wan Q; Revathy KS; Whang I; Noh JK; Kim S; Park MA; Lee J
Fish Shellfish Immunol; 2014 Sep; 40(1):304-18. PubMed ID: 24945570
[TBL] [Abstract][Full Text] [Related]
57. Constitutively active chemokine CXC receptors.
Han X
Adv Pharmacol; 2014; 70():265-301. PubMed ID: 24931199
[TBL] [Abstract][Full Text] [Related]
58. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
[TBL] [Abstract][Full Text] [Related]
59. Do viral chemokines modulate Kaposi's sarcoma?
Dittmer D; Kedes DH
Bioessays; 1998 May; 20(5):367-70. PubMed ID: 9670810
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
